Evaxion Biotech A/S fell 20.1% on Thursday, November 19, 2026, on 149,500 shares. Headlines around the move:
Evaxion Biotech A/S (EVAX:NASDAQ) closed at $2.25 on November 20, 2026, up 10.84% on the day. The stock trades 67.5% below its 52-week high of $6.92 and 10.8% above its 52-week low of $2.03. Over the past year, it lost 56.6%. Evaxion Biotech A/S is part of the Health Care sector.
In 252 trading sessions since November 20, 2025, EVAX closed higher on 115 days (46%). Its best day was October 20, 2026 (+21.62%) and its worst was November 19, 2026 (-20.08%). The stock moved 10% or more in a single session 13 times. It opened at least 5% above the previous day's high 3 times.
Evaxion Biotech AS is an artificial intelligence immunology platform company. It uses proprietary AI technology, engineering expertise, and drug development know-how to simulate the human immune system and generate predictive models to identify and develop efficacious immunotherapies for patients in the global market. Its two lead product candidates are EVX-01 and EVX-02, for the treatment of various cancers.
Find more stocks like EVAX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.